| Financial Year |
March 31 2023 |
| Monetary Funds |
519,416,006.48 |
| Held-for-trading Financial Assets |
592,422,041.11 |
| Notes Receivable |
-- |
| Accounts Receivable |
82,482,495.34 |
| Advances to Suppliers |
5,340,730.37 |
| Other Receivables |
25,785,938.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
310,445,552.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,491,194.35 |
| Total Current Assets |
1,547,383,958.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,282,717.57 |
| Investment Properties |
707,233,818.59 |
| Fixed Assetes |
154,352,122.02 |
| Under-construction Projects |
14,603,589.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,674,808.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,213,261.92 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
4,731,888.64 |
| Sub-Total of Non-Current Assets |
1,455,951,523.67 |
| Total Assets |
3,003,335,482.31 |
| Short-Term Loans |
150,127,111.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
32,480,534.09 |
| Accounts Received In Advance |
16,479,422.96 |
| Employee Compensation Payable |
1,443,237.25 |
| Taxes Payable |
24,478,139.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
117,637,403.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,484,313.33 |
| Other Current Liabilities |
699,396.89 |
| Sub-Total of Current Liabilities |
385,877,970.43 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,544,700.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
77,771,959.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
206,604,607.97 |
| Total Liabilities |
592,482,578.40 |
| Paid-In Capital(Or Share Stock) |
1,054,027,073.00 |
| Capital Surplus |
156,441,088.47 |
| Surplus Reserve |
296,319,621.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
867,695,492.70 |
| Minority Stockholder's Interest |
36,369,628.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,374,483,275.73 |
| Owner's Equity（Stockholder's Equity） |
2,410,852,903.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,003,335,482.31 |
